Joseph Monahan

Joseph Monahan

Chief Scientific OfficeratAclaris Therapeutics· In proxies 2021–2023

Pay in FY2022-47% from the year before · Aclaris Therapeutics stock +8.3% the same year

Joseph Monahan was paid $2.8M in FY2022 (Dec), down 47%. Aclaris Therapeutics stock rose 8.3% that year.

Pay$100 in the stock at the end of FY20 → $243
Pay is from the Summary Compensation Table of each Aclaris Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Aclaris TherapeuticsPublic company · 5 yr
    • Chief Scientific Officer2021 – Present · 5 yrStock in role -48%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?